AEON Biopharma, Inc. (AEON)

AEON Biopharma Market Cap

AEON Biopharma has a market cap or net worth of $249.31 million as of April 19, 2024. Its market cap has decreased by -28.95% in one year.

• Market Cap: 249.31M
• Enterprise Value: 244.15M
• 1-Year Change: -28.95%
• Ranking: #3468
• Category: Micro-Cap
• Stock Price: $6.54

Market Cap Chart

Since February 9, 2021, AEON Biopharma's market cap has decreased from $259.00M to $249.31M, a decrease of -3.74%. That is a compound annual growth rate of -1.19%.

Market Cap History

Date	Market Cap	% Change
Apr 17, 2024	252.30M	-1.45%
Apr 16, 2024	256.00M	-2.96%
Apr 15, 2024	263.80M	-6.59%
Apr 12, 2024	282.40M	-10.69%
Apr 11, 2024	316.20M	-
Apr 10, 2024	316.20M	7.70%
Apr 9, 2024	293.60M	-7.59%
Apr 8, 2024	317.70M	1.79%
Apr 5, 2024	312.10M	1.93%
Apr 4, 2024	306.20M	1.86%
Apr 3, 2024	300.60M	4.78%
Apr 2, 2024	286.90M	3.91%
Apr 1, 2024	276.10M	-35.95%
Mar 28, 2024	431.10M	-4.75%
Mar 27, 2024	452.60M	6.75%
Mar 26, 2024	424.00M	-3.13%
Mar 25, 2024	437.70M	2.96%
Mar 22, 2024	425.10M	4.96%
Mar 21, 2024	405.00M	-13.42%
Mar 20, 2024	467.80M	-12.58%
Mar 19, 2024	535.10M	-11.60%
Mar 18, 2024	605.30M	3.42%
Mar 15, 2024	585.30M	8.63%
Mar 14, 2024	538.80M	14.25%
Mar 13, 2024	471.60M	2.34%

View and export this data all the way back to 2021. Sign Up Today.

Related Stocks

Company	Market Cap
Immutep	268.68M
Sight Sciences	266.60M
Fennec Pharmaceuticals	262.87M
2seventy bio	259.63M
Ventyx Biosciences	259.53M
Inovio Pharmaceuticals	258.71M
AngioDynamics	253.54M
Telomir Pharmaceuticals	251.09M